OKUR Earnings & Financial Statements
OnKure Therapeutics, Inc.
$2.16
-$0.09(-4.00%)
28
Overall
60
Value
9
Tech
15
Quality
Market Cap
$91.12M
Volume
55.96K
52W Range
$2.13 - $5.38
Target Price
$15.50
OKUR earnings and financial statements: OnKure Therapeutics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
OKUR Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating income | -$62.95M | -$54.39M | -$36.93M | -$53.85M | -$39.82M |
| EBITDA | -$58.69M | -$51.87M | -$34.75M | -$51.87M | -$39.52M |
| Net income | -$59.52M | -$52.67M | -$35.31M | -$51.95M | -$39.77M |
| EPS (diluted) | $-4.40 | $-15.28 | $-25.20 | $-2.12 | $-2.19 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $62.12M | $114.91M | $35.73M | $108.18M | $154.02M |
| Total liabilities | $5.93M | $11.08M | $7.75M | $8.21M | $6.81M |
| Shareholders’ equity | $56.18M | $103.83M | -$101.84M | $99.97M | $147.21M |
| Cash and equivalents | $59.05M | $110.76M | $29.88M | $19.93M | $124.66M |
| Long-term debt | - | $549.0K | $466.0K | $1.06M | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$51.83M | -$51.12M | -$34.55M | -$26.95M | -$37.98M |
| Capital expenditure | -$46.0K | -$52.0K | -$246.0K | -$1.13M | -$198.0K |
| Free cash flow | -$51.87M | -$51.17M | -$34.79M | -$28.09M | -$38.18M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OKUR | $2.16 | -4.0% | 55.96K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get OnKure Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW